2020
Is microvascular dysfunction a systemic disorder with common biomarkers found in the heart, brain, and kidneys? — A scoping review
Nowroozpoor A, Gutterman D, Safdar B. Is microvascular dysfunction a systemic disorder with common biomarkers found in the heart, brain, and kidneys? — A scoping review. Microvascular Research 2020, 134: 104123. PMID: 33333140, DOI: 10.1016/j.mvr.2020.104123.Peer-Reviewed Original ResearchConceptsMicrovascular dysfunctionUnderlying systemic processC-reactive proteinLow-density cholesterolMulti-system involvementUric acidDifferent disease entitiesMulti-system manifestationsVon Willebrand factorNT-proBNPEndothelial dysfunctionTotal cholesterolClinical evidenceImmune activationSystemic disordersVitamin DIL-6Asymmetric dimethylarginineBlood biomarkersInforms cliniciansDisease entityCystatin CVital organsDysfunctionCommon biomarkers
2015
Angiotensin converting enzyme inhibition increases ADMA concentration in patients on maintenance hemodialysis – a randomized cross-over study
Gamboa JL, Pretorius M, Sprinkel KC, Brown NJ, Ikizler TA. Angiotensin converting enzyme inhibition increases ADMA concentration in patients on maintenance hemodialysis – a randomized cross-over study. BMC Nephrology 2015, 16: 167. PMID: 26494370, PMCID: PMC4618919, DOI: 10.1186/s12882-015-0162-x.Peer-Reviewed Original ResearchConceptsEnd-stage renal diseaseAngiotensin receptor blockersMaintenance hemodialysisCross-over studyADMA levelsAsymmetric dimethylarginineACE inhibitionADMA productionADMA concentrationsShort-term ACE inhibitionRandomized cross-over studyIntracellular ADMA concentrationStudy of patientsEffect of bradykininB2 receptor stimulationACE inhibitor-induced increaseInhibitor-induced increaseRamipril treatmentCardiovascular morbidityReceptor blockersEndothelial dysfunctionRenal diseaseBradykinin levelsBackgroundEndothelial dysfunctionDialysis session
2011
A simple and fast liquid chromatography–tandem mass spectrometry method for measurement of underivatized l-arginine, symmetric dimethylarginine, and asymmetric dimethylarginine and establishment of the reference ranges
El-Khoury JM, Bunch DR, Reineks E, Jackson R, Steinle R, Wang S. A simple and fast liquid chromatography–tandem mass spectrometry method for measurement of underivatized l-arginine, symmetric dimethylarginine, and asymmetric dimethylarginine and establishment of the reference ranges. Analytical And Bioanalytical Chemistry 2011, 402: 771-779. PMID: 22124751, DOI: 10.1007/s00216-011-5462-9.Peer-Reviewed Original ResearchConceptsFast liquid chromatography–tandem mass spectrometry methodAnalytical cycle timeChromatography-tandem mass spectrometry methodLiquid chromatography-tandem mass spectrometry methodMinimum sample preparationMass spectrometry methodLiquid chromatography-tandem mass spectrometryChromatography-tandem mass spectrometryAsymmetric dimethylarginineSymmetric dimethylarginineLC-MS/MS methodMass spectrometerFormic acidSpectrometry methodMass spectrometrySilica columnProtein precipitationSample preparationInternal standardAmmonium acetateMS methodGlomerular filtration rateAnalytesNitric oxide synthaseΜM
2007
Presence of asymmetric dimethylarginine gradients across high-grade lesions in patients with coronary artery disease
Joyal D, Leya F, Al-Chekakie M, Arab D, Dieter RS, Morshedi-Meibodi A, Lewis B, Steen L, Fareed J, Hoppenstead D, Akar JG. Presence of asymmetric dimethylarginine gradients across high-grade lesions in patients with coronary artery disease. Coronary Artery Disease 2007, 18: 471-475. PMID: 17700219, DOI: 10.1097/mca.0b013e32818be79c.Peer-Reviewed Original ResearchConceptsPercutaneous coronary interventionCoronary interventionCoronary lesionsAsymmetric dimethylarginineEndothelial dysfunctionAsymmetric dimethylarginine accumulationAsymmetric dimethylarginine levelsGeneralized endothelial dysfunctionPeripheral venous siteSystemic venous levelsAsymmetric dimethylarginine concentrationsCoronary artery diseaseHigh-grade lesionsNitric oxide synthaseLevels 24 hDimethylarginine levelsDimethylarginine concentrationsCoronary ostiumArtery diseaseSystemic markersVenous levelsCoronary bedFocal injuryOxide synthaseVenous sites
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply